Insiders Cantargia AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 06:59:40 2024-04-30 am EDT			5-day change	1st Jan Change
3.336 ^SEK	-2.74%		-10.56%	-10.75%

Apr. 17	Cantargia Publishes New Data on the Can10 Antibody, Detailing Its Interaction with IL1RAP and Functional Inhibition	CI
Apr. 10	Cantargia AB Publishes Preclinical Data on the Potential of CAN10 in Systemic Sclerosis in A Leading Scientific Journal	CI

Cantargia AB Promotes David Liberg to Chief Scientific Officer	23-06-01	CI
Cantargia : The nomination committees statement	23-04-24	PU
Cantargia Appoints Patrik Renblad as Chief Financial Officer	23-02-01	CI
Cantargia AB Announces Nomination Committee Appointments	22-11-21	CI
Nomination Committee appointed ahead of 2023 Annual General Meeting	22-11-21	AQ
Cantargia AB Announces Executive Changes	22-07-08	CI
Cantargia AB Strengthens Executive Management in Preparation for Late-Stage Clinical Development	22-03-10	CI
(R) Nomination Committee appointed ahead of 2022 Annual General Meeting	21-10-29	PU
Nomination Committee appointed ahead of 2022 Annual General Meeting	21-10-29	AQ
Cantargia AB Announces Appointment of Nomination Committee	21-10-29	CI
Cantargia AB Elect Magnus Nilsson and Damian Marron as New Board Members	21-05-26	CI
Cantargia AB Announces Claus Asbjørn Andersson Declined Re-Election	21-04-27	CI
Cantargia : Changes to Cantargia’s nomination committee	20-12-21	PU
Cantargia : Changes to Cantargia's nomination committee	20-12-21	AQ
Cantargia AB Announces Nomination Committee Changes	20-12-21	CI
Cantargia AB Announces Executive Changes	20-10-20	CI
Cantargia : Nomination Committee appointed ahead of 2021 Annual General Meeting	20-10-20	PU
Cantargia : Nomination Committee appointed ahead of 2021 Annual General Meeting	20-10-20	AQ
Cantargia : Cantargia’s nomination committee proposes a new board member	20-09-21	PU
Cantargia : nomination committee proposes a new board member	20-09-21	AQ

No results for this search